School of Medicine
Showing 1-20 of 44 Results
-
Dhriti Nagar
Postdoctoral Scholar, Neonatal and Developmental Medicine
BioPremature birth is a leading cause of developmental and neuropsychiatric disorders in children. One of the factors causing these defects is lowered levels of available oxygen (hypoxia) in the newborn due to immature lungs. My research focuses on understanding the cellular and molecular mechanisms underlying hypoxia-induced developmental disorders of the nervous system due to preterm birth.
-
Michitaka Nakano
Basic Life Research Scientist, Medicine - Med/Hematology
BioI am a MD/PhD postdoctoral fellow and medical oncologist with a long-standing interest in translational cancer research. My long-term goal is to be a lab-based physician-scientist and independent academic researcher, translating basic cancer research, and mentoring next-generation scientists. My thesis work in Japan focused on cancer stem cell equilibrium by uniquely applying organoid culture as a method to elucidate cancer stem cell dynamics, which was awarded in Japanese Cancer Association. Along with the development of the field represented by success in T cell checkpoint, my interest gradually shifted to immune oncology while I examined numerous numbers of cancer patients as a medical oncology fellow. My postdoctoral fellowship at Calvin Kuo Lab in Stanford (2019-present) focuses on tumor immune microenvironment. Kuo lab developed a unique 3D air-liquid interface (ALI) organoid system that cultures tumors while preserving their endogenous infiltrating immune cells (T,B ,NK, Myeloid cells). My postdoctoral work will prove the significance of organoids as a translational tool to discover tumor-immune interaction by novel checkpoint inhibitors for immune cells, which can be broadly applicable to basic cancer biology, precision medicine, therapeutics validation and biomarker discovery.
-
Shingo Narita
Postdoctoral Scholar, Cardiovascular Institute
BioPostdoctoral Fellow
Cardiologist (Japan)
Research expertise: AL amyloid cardiomyopathy, Cardiac regeneration -
Rohollah Nasiri
Postdoctoral Scholar, Radiation Physics
Current Research and Scholarly InterestsMy research focuses on advancing cancer treatment through the integration of tumor-on-a-chip models with radiation therapy
-
Fateme Nateghi Haredasht
Postdoctoral Scholar, Biomedical Informatics
BioAs a postdoctoral scholar at the Stanford Center for Biomedical Informatics Research, I find myself at the exciting intersection of machine learning and healthcare. My journey began with a PhD in Biomedical Sciences from KU Leuven in Belgium, where I delved into the complexities of machine learning algorithms and their transformative potential in healthcare settings. My research, particularly focused on adapting these algorithms for time-to-event data (a method used for predicting specific events in a patient’s future), has not only been a challenging endeavor but also a deeply fulfilling one.
Now at Stanford, my role involves not just advancing machine learning integration in healthcare, but also collaborating with a diverse team of experts. Together, we're striving to unravel complex healthcare challenges and improve patient outcomes. -
Amy Nava
Postdoctoral Scholar, Molecular and Cellular Physiology
BioMy long-term scientific goal entails establishing an interdisciplinary and diverse laboratory focused on mitigating antibiotic resistance. My research comprises three central elements: elucidating the bacterial calcium transduction pathway, biosurfactants for treating deep tissue infections, and understanding how calcium signaling regulates bacterial pathogenesis mechanisms.
-
Shaghayegh Navabpour
Postdoctoral Scholar, Pathology
Current Research and Scholarly InterestsMy research interests lie at the intersection of genetics and epigenetics, with a current focus on cancer and drug development. I am particularly interested in bifunctional small molecules, such as Transcriptional/Epigenetic Chemical Inducers of Proximity (TCIPs). My work now concentrates on designing, synthesizing, and testing new TCIPs that utilize various transcription factors or histone modifiers to target genes implicated in different types of cancer. Through this approach, I aim to develop innovative therapies that can more precisely and effectively combat cancer, especially to ease the treatment process for vulnerable patients, such as children and adolescents.
